{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:47:29Z","timestamp":1776872849536,"version":"3.51.2"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina de Familia. SEMERGEN"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.semerg.2026.102720","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T20:16:23Z","timestamp":1771359383000},"page":"102720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Psoriasis moderada-grave y comorbilidad asociada en pacientes en tratamiento biol\u00f3gico: implicaciones para atenci\u00f3n primaria"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7253-9255","authenticated-orcid":false,"given":"J.","family":"Gonz\u00e1lez Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8789-6783","authenticated-orcid":false,"given":"M.","family":"Ara-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1102-5020","authenticated-orcid":false,"given":"A.P.","family":"Ruiz-Cortegoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5066-5014","authenticated-orcid":false,"given":"L.","family":"Prieto-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semerg.2026.102720_bib0155","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.semerg.2026.102720_bib0160","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/1346-8138.15840","article-title":"Psoriasis: comorbidities","volume":"48","author":"Yamazaki","year":"2021","journal-title":"J Dermatol."},{"key":"10.1016\/j.semerg.2026.102720_bib0165","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/jamadermatol.2018.3631","article-title":"Association of psoriasis with inflammatory bowel disease: a systematic review and meta-analysis","volume":"154","author":"Fu","year":"2018","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.semerg.2026.102720_bib0170","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1016\/j.jaad.2018.11.036","article-title":"Psoriasis and hidradenitis suppurativa: a large-scale population-based study","volume":"88","author":"Kridin","year":"2023","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.semerg.2026.102720_bib0175","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ecl.2021.05.002","article-title":"Screening for diabetes and prediabetes","volume":"50","author":"Duan","year":"2021","journal-title":"Endocrinol Metab Clin North Am."},{"key":"10.1016\/j.semerg.2026.102720_bib0180","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology."},{"key":"10.1016\/j.semerg.2026.102720_bib0185","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology."},{"key":"10.1016\/j.semerg.2026.102720_bib0190","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.001180","article-title":"A comprehensive definition for metabolic syndrome","volume":"2","author":"Huang","year":"2009","journal-title":"Dis Model Mech."},{"key":"10.1016\/j.semerg.2026.102720_bib0195","first-page":"151","article-title":"Non-Alcoholic Fatty Liver Disease (NAFLD) in patients with psoriasis: a review of the hepatic effects of systemic therapies","volume":"11","author":"Balak","year":"2021","journal-title":"Psoriasis (Auckl)."},{"key":"10.1016\/j.semerg.2026.102720_bib0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25105203","article-title":"Drug-Induced Fatty Liver Disease (DIFLD): a comprehensive analysis of clinical, biochemical, and histopathological data for mechanisms identification and consistency with current adverse outcome pathways","volume":"25","author":"L\u00f3pez-Pascual","year":"2024","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.semerg.2026.102720_bib0205","doi-asserted-by":"crossref","first-page":"864185","DOI":"10.3389\/fmed.2022.864185","article-title":"Endothelial dysfunction in psoriasis: an updated review","volume":"9","author":"Anyfanti","year":"2022","journal-title":"Front Med (Lausanne)."},{"key":"10.1016\/j.semerg.2026.102720_bib0210","first-page":"E168","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association","volume":"42","author":"Barton Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.semerg.2026.102720_bib0215","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ad.2025.01.008","article-title":"\u00cdndice triglic\u00e9ridos\/glucosa combinado con par\u00e1metros antropom\u00e9tricos: una herramienta prometedora para el cribado de EHGNA en los pacientes con psoriasis","volume":"116","author":"Gonz\u00e1lez Fern\u00e1ndez","year":"2025","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.semerg.2026.102720_bib0220","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ad.2024.09.021","article-title":"El \u00edndice triglic\u00e9ridos-glucosa como predictor de eventos cardiovasculares en pacientes con psoriasis y tratamiento sist\u00e9mico: un estudio observacional de 150 pacientes","volume":"116","author":"Fern\u00e1ndez Domper","year":"2025","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.semerg.2026.102720_bib0225","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/jdv.19191","article-title":"Statins and psoriasis: position statement by the Psoriasis Task Force of the European Academy of Dermatology and Venerology","volume":"37","author":"Gonzalez-Cantero","year":"2023","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.semerg.2026.102720_bib0230","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2147\/VHRM.S464471","article-title":"Cardiovascular considerations and implications for treatment in psoriasis: an updated review","volume":"20","author":"Mehta","year":"2024","journal-title":"Vasc Health Risk Manag."},{"key":"10.1016\/j.semerg.2026.102720_bib0235","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2105\/AJPH.2023.307233","article-title":"SARS-CoV-2 infection during the first and second pandemic waves in Spain: the ENE\u2013COVID study","volume":"113","author":"P\u00e9rez-G\u00f3mez","year":"2023","journal-title":"Am J Public Health."},{"key":"10.1016\/j.semerg.2026.102720_bib0240","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jaad.2023.12.070","article-title":"Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation","volume":"90","author":"Chat","year":"2024","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.semerg.2026.102720_bib0245","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13632","article-title":"Covid-19 and exacerbation of psoriasis","volume":"33","author":"Ozaras","year":"2020","journal-title":"Dermatol Ther."},{"key":"10.1016\/j.semerg.2026.102720_bib0250","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ad.2018.08.006","article-title":"VitaminaD y la piel. Una revisi\u00f3n para dermat\u00f3logos","volume":"110","author":"Navarro-Trivi\u00f1o","year":"2019","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.semerg.2026.102720_bib0255","doi-asserted-by":"crossref","first-page":"445","DOI":"10.5114\/ada.2016.63883","article-title":"Serum vitaminD level \u2014 the effect on the clinical course of psoriasis","volume":"6","author":"Bergler-Czop","year":"2016","journal-title":"Postepy Dermatol Allergol."},{"key":"10.1016\/j.semerg.2026.102720_bib0260","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11154-017-9411-6","article-title":"VitaminD and its role in psoriasis: an overview of the dermatologist and nutritionist","volume":"18","author":"Barrea","year":"2017","journal-title":"Rev Endocr Metab Disord."},{"key":"10.1016\/j.semerg.2026.102720_bib0265","author":"Nast","year":"2023","journal-title":"EuroGuiDerm guideline for the systemic treatment of psoriasis vulgaris"},{"key":"10.1016\/j.semerg.2026.102720_bib0270","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ad.2022.01.024","volume":"113","author":"Carrascosa","year":"2022","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.semerg.2026.102720_bib0275","first-page":"18","article-title":"MASLD and liver fibrosis in patients with psoriasis receiving IL-17 or IL-23 inhibitors: a systematic review","author":"Gonz\u00e1lez Fern\u00e1ndez","year":"2025","journal-title":"Therap Adv Gastroenterol."},{"key":"10.1016\/j.semerg.2026.102720_bib0280","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/jdv.16926","article-title":"EuroGuiDerm Guideline on the systemic treatment of psoriasis vulgaris \u2014 Part 2: specific clinical and comorbid situations","volume":"35","author":"Nast","year":"2021","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.semerg.2026.102720_bib0285","unstructured":"Systemic psoriasis therapies and comorbid disease in patients with psoriasis: a review of potential risks and benefits | JCAD \u2014 The Journal of Clinical and Aesthetic Dermatology [consultado 18 May 2025]. Disponible en: https:\/\/jcadonline.com\/psoriasis-comorbidities-june-2019\/"},{"key":"10.1016\/j.semerg.2026.102720_bib0290","first-page":"52","article-title":"Efecto de la terapia biol\u00f3gica sobre el metabolismo seo en las enfermedades inflamatorias articulares","volume":"15","author":"Hern\u00e1ndez","year":"2006","journal-title":"REEMO: Revista Espa\u00f1ola de Enfermedades Metab\u00f3licas \u00d3seas."},{"key":"10.1016\/j.semerg.2026.102720_bib0295","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ad.2021.10.003","volume":"113","author":"Carrascosa","year":"2022","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.semerg.2026.102720_bib0300","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jdin.2024.02.019","article-title":"Real-world outcomes in patients with malignancy and moderate-to-severe psoriasis treated with guselkumab","volume":"16","author":"Gracia Caza\u00f1a","year":"2024","journal-title":"JAAD Int."}],"container-title":["Medicina de Familia. SEMERGEN"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359326000377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359326000377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:52:48Z","timestamp":1776869568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1138359326000377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1138359326000377"],"URL":"https:\/\/doi.org\/10.1016\/j.semerg.2026.102720","relation":{},"ISSN":["1138-3593"],"issn-type":[{"value":"1138-3593","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psoriasis moderada-grave y comorbilidad asociada en pacientes en tratamiento biol\u00f3gico: implicaciones para atenci\u00f3n primaria","name":"articletitle","label":"Article Title"},{"value":"Medicina de Familia. SEMERGEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semerg.2026.102720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN). Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102720"}}